Clarithromycin resistance ( CLA-R , odds ratio ( OR ) = 8.34 ( 3.13-22 .26 ) , P < 0.001 ) and metronidazole resistance ( MET-R , OR = 7.14 ( 1.52-33 .53 ) , P = 0.013 ) both independently predicted treatment failure in the SQT group .